Innate Pharma S.A. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,892.00
19,647.00
6,706.00
12,640.00
48,385.00
3,049
Depreciation, Depletion & Amortization
880.00
2,344.00
2,655.00
3,263.00
4,393.00
7,401
Other Funds
422.00
-
-
-
-
5,458
Funds from Operations
5,969.00
16,999.00
3,718.00
13,813.00
29,751.00
15,908
Changes in Working Capital
5,142.00
1,300.00
211,491.00
50,788.00
16,980.00
47,096
Net Operating Cash Flow
11,111.00
18,299.00
207,773.00
36,975.00
46,731.00
31,188
Capital Expenditures
433.00
2,343.00
7,397.00
9,393.00
6,026.00
Sale of Fixed Assets & Businesses
116.00
543.00
-
-
-
Purchase/Sale of Investments
958.00
2,023.00
115,872.00
68,204.00
24,876.00
Net Investing Cash Flow
958.00
3,823.00
122,297.00
60,510.00
30,902.00
Issuance/Reduction of Debt, Net
314.00
613.00
452.00
685.00
537.00
Net Financing Cash Flow
19,821.00
48,115.00
3,171.00
478.00
1,028.00
Net Change in Cash
7,775.00
25,926.00
88,584.00
23,036.00
76,539.00
Free Cash Flow
11,544.00
20,642.00
206,701.00
38,325.00
49,695.00
Other Sources
438.00
-
972.00
1,699.00
-
Change in Capital Stock
19,085.00
48,728.00
3,623.00
207.00
491.00
Exchange Rate Effect
23.00
67.00
63.00
21.00
66.00
Other Uses
121.00
-
-
-
-
About Innate Pharma
View Profile
